nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCD—Signaling by FGFR—AKT1—ocular cancer	0.000656	0.000656	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000656	0.000656	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—CDKN1B—ocular cancer	0.000656	0.000656	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—CDKN1A—ocular cancer	0.000655	0.000655	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—AKT1—ocular cancer	0.000653	0.000653	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—CDKN1A—ocular cancer	0.000652	0.000652	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RBL1—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—RPL39—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—AKT1—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—AKT1—ocular cancer	0.00065	0.00065	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—CDKN1A—ocular cancer	0.000649	0.000649	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—CDKN1B—ocular cancer	0.000647	0.000647	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—ocular cancer	0.000646	0.000646	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.000642	0.000642	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TFDP1—ocular cancer	0.000639	0.000639	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—AKT1—ocular cancer	0.000637	0.000637	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—CDK2—ocular cancer	0.00063	0.00063	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HDAC1—ocular cancer	0.000629	0.000629	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Regulation of mRNA stability by proteins that bind AU-rich elements—AKT1—ocular cancer	0.000625	0.000625	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000622	0.000622	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000613	0.000613	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—AKT1—ocular cancer	0.000611	0.000611	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—AKT1—ocular cancer	0.000611	0.000611	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—CDKN1A—ocular cancer	0.00061	0.00061	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.00061	0.00061	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—RBBP4—ocular cancer	0.000607	0.000607	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—AKT1—ocular cancer	0.000606	0.000606	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—CDKN1A—ocular cancer	0.000605	0.000605	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—HRAS—ocular cancer	0.000604	0.000604	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.0006	0.0006	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.0006	0.0006	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—AKT1—ocular cancer	0.000598	0.000598	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—CDKN1A—ocular cancer	0.000597	0.000597	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN2B—ocular cancer	0.000595	0.000595	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.000595	0.000595	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000594	0.000594	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND2—ocular cancer	0.000593	0.000593	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—HDAC1—ocular cancer	0.000593	0.000593	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Corticotropin-releasing hormone—AKT1—ocular cancer	0.000593	0.000593	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.000592	0.000592	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.000586	0.000586	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—ocular cancer	0.000575	0.000575	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000574	0.000574	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—HDAC1—ocular cancer	0.000571	0.000571	CbGpPWpGaD
Ingenol Mebutate—PRKCA—M Phase—RB1—ocular cancer	0.000565	0.000565	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—TFDP1—ocular cancer	0.000564	0.000564	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—HRAS—ocular cancer	0.000561	0.000561	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000547	0.000547	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—E2F1—ocular cancer	0.000546	0.000546	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000541	0.000541	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.000541	0.000541	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SAG—ocular cancer	0.000536	0.000536	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—AKT1—ocular cancer	0.000533	0.000533	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN2B—ocular cancer	0.000532	0.000532	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HDAC1—ocular cancer	0.00053	0.00053	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—HRAS—ocular cancer	0.000525	0.000525	CbGpPWpGaD
Ingenol Mebutate—PRKCA—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.000525	0.000525	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TFDP1—ocular cancer	0.000524	0.000524	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—RB1—ocular cancer	0.000518	0.000518	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of mRNA—AKT1—ocular cancer	0.000515	0.000515	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—CDKN2B—ocular cancer	0.000512	0.000512	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000512	0.000512	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MAML2—ocular cancer	0.000508	0.000508	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—MDM2—ocular cancer	0.000503	0.000503	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by VEGF—AKT1—ocular cancer	0.000496	0.000496	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—MDM2—ocular cancer	0.000494	0.000494	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—MDM2—ocular cancer	0.00049	0.00049	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—E2F1—ocular cancer	0.000488	0.000488	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—ocular cancer	0.00048	0.00048	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—HRAS—ocular cancer	0.000477	0.000477	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000476	0.000476	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN2B—ocular cancer	0.000475	0.000475	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000475	0.000475	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNA11—ocular cancer	0.000474	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—E2F5—ocular cancer	0.000474	0.000474	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—HRAS—ocular cancer	0.000472	0.000472	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDK2—ocular cancer	0.000471	0.000471	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—E2F4—ocular cancer	0.000464	0.000464	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000456	0.000456	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RBL1—ocular cancer	0.000455	0.000455	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CDKN1B—ocular cancer	0.000451	0.000451	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MAML2—ocular cancer	0.000448	0.000448	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CDKN1B—ocular cancer	0.000448	0.000448	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—CDK2—ocular cancer	0.000446	0.000446	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDK4—ocular cancer	0.000445	0.000445	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNA11—ocular cancer	0.000443	0.000443	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Metabolism of RNA—AKT1—ocular cancer	0.000441	0.000441	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNAQ—ocular cancer	0.000441	0.000441	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—EP300—ocular cancer	0.000436	0.000436	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—HRAS—ocular cancer	0.000431	0.000431	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNA11—ocular cancer	0.000431	0.000431	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—HRAS—ocular cancer	0.000429	0.000429	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000427	0.000427	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—HRAS—ocular cancer	0.000427	0.000427	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—HRAS—ocular cancer	0.000425	0.000425	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—TGFB1—ocular cancer	0.000423	0.000423	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—HRAS—ocular cancer	0.000423	0.000423	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDK2—ocular cancer	0.000421	0.000421	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—AKT1—ocular cancer	0.000421	0.000421	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MAML2—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—AKT1—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—CDKN1A—ocular cancer	0.000416	0.000416	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—CDKN1A—ocular cancer	0.000413	0.000413	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNAQ—ocular cancer	0.000412	0.000412	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.000403	0.000403	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNAQ—ocular cancer	0.0004	0.0004	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDK4—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—HRAS—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—HRAS—ocular cancer	0.000398	0.000398	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—E2F3—ocular cancer	0.000395	0.000395	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—HRAS—ocular cancer	0.000394	0.000394	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EP300—ocular cancer	0.000393	0.000393	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000391	0.000391	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000391	0.000391	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—HRAS—ocular cancer	0.000389	0.000389	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—RB1—ocular cancer	0.000387	0.000387	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—AKT1—ocular cancer	0.000381	0.000381	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TGFB1—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—AKT1—ocular cancer	0.000379	0.000379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—AKT1—ocular cancer	0.000377	0.000377	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000377	0.000377	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—AKT1—ocular cancer	0.000375	0.000375	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—AKT1—ocular cancer	0.000373	0.000373	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HDAC1—ocular cancer	0.000371	0.000371	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TFDP1—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—TGFB1—ocular cancer	0.000367	0.000367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—EP300—ocular cancer	0.000364	0.000364	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—HRAS—ocular cancer	0.000361	0.000361	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000352	0.000352	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—AKT1—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—AKT1—ocular cancer	0.000351	0.000351	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—AKT1—ocular cancer	0.000348	0.000348	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—RB1—ocular cancer	0.000346	0.000346	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000345	0.000345	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—AKT1—ocular cancer	0.000343	0.000343	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—ocular cancer	0.00034	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN2B—ocular cancer	0.000333	0.000333	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00033	0.00033	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—HDAC1—ocular cancer	0.000328	0.000328	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—MYC—ocular cancer	0.000318	0.000318	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—ocular cancer	0.000312	0.000312	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000311	0.000311	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—E2F1—ocular cancer	0.000305	0.000305	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HDAC1—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNA11—ocular cancer	0.000304	0.000304	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1B—ocular cancer	0.000301	0.000301	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—HRAS—ocular cancer	0.000299	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of mRNA—AKT1—ocular cancer	0.000296	0.000296	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MDM2—ocular cancer	0.000295	0.000295	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—CDKN2B—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—AKT1—ocular cancer	0.000294	0.000294	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MAML2—ocular cancer	0.000292	0.000292	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—ocular cancer	0.000287	0.000287	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MDM2—ocular cancer	0.000285	0.000285	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNAQ—ocular cancer	0.000283	0.000283	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MDM2—ocular cancer	0.000282	0.000282	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDKN1A—ocular cancer	0.000278	0.000278	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—HRAS—ocular cancer	0.000276	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN2B—ocular cancer	0.000273	0.000273	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—HRAS—ocular cancer	0.000271	0.000271	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1B—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—HRAS—ocular cancer	0.000269	0.000269	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—EP300—ocular cancer	0.000265	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—AKT1—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MDM2—ocular cancer	0.000264	0.000264	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1B—ocular cancer	0.000261	0.000261	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1B—ocular cancer	0.000257	0.000257	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNA11—ocular cancer	0.000254	0.000254	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism of RNA—AKT1—ocular cancer	0.000253	0.000253	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—EP300—ocular cancer	0.000251	0.000251	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDKN1A—ocular cancer	0.000249	0.000249	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1B—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDKN1A—ocular cancer	0.000241	0.000241	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—AKT1—ocular cancer	0.000239	0.000239	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—AKT1—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—CDKN1A—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—EP300—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNAQ—ocular cancer	0.000237	0.000237	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—MYC—ocular cancer	0.000231	0.000231	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EP300—ocular cancer	0.000229	0.000229	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EP300—ocular cancer	0.000226	0.000226	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—CDKN1A—ocular cancer	0.000222	0.000222	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by Wnt—AKT1—ocular cancer	0.00022	0.00022	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TGFB1—ocular cancer	0.000218	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HDAC1—ocular cancer	0.000213	0.000213	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EP300—ocular cancer	0.000211	0.000211	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MYC—ocular cancer	0.000206	0.000206	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—MYC—ocular cancer	0.000198	0.000198	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN2B—ocular cancer	0.000191	0.000191	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MDM2—ocular cancer	0.000185	0.000185	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MYC—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFB1—ocular cancer	0.000184	0.000184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—ocular cancer	0.000179	0.000179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—E2F1—ocular cancer	0.000175	0.000175	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—HRAS—ocular cancer	0.000172	0.000172	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—HRAS—ocular cancer	0.000171	0.000171	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1B—ocular cancer	0.000169	0.000169	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—AKT1—ocular cancer	0.000167	0.000167	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MDM2—ocular cancer	0.000164	0.000164	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—ocular cancer	0.000161	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—HRAS—ocular cancer	0.000157	0.000157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CDKN1A—ocular cancer	0.000156	0.000156	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—HRAS—ocular cancer	0.000154	0.000154	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—AKT1—ocular cancer	0.000152	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—AKT1—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MDM2—ocular cancer	0.000151	0.000151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1B—ocular cancer	0.00015	0.00015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EP300—ocular cancer	0.000148	0.000148	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—HRAS—ocular cancer	0.000145	0.000145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—AKT1—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1B—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDKN1A—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—AKT1—ocular cancer	0.000138	0.000138	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—AKT1—ocular cancer	0.000136	0.000136	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EP300—ocular cancer	0.000131	0.000131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MYC—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFB1—ocular cancer	0.000129	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—AKT1—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—CDKN1A—ocular cancer	0.000128	0.000128	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EP300—ocular cancer	0.000121	0.000121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—MYC—ocular cancer	0.000114	0.000114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MDM2—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MYC—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFB1—ocular cancer	0.000106	0.000106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—EP300—ocular cancer	0.000102	0.000102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—HRAS—ocular cancer	0.000101	0.000101	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—HRAS—ocular cancer	9.85e-05	9.85e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1B—ocular cancer	9.68e-05	9.68e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—AKT1—ocular cancer	9.57e-05	9.57e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—ocular cancer	9.23e-05	9.23e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—HRAS—ocular cancer	9e-05	9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—AKT1—ocular cancer	8.94e-05	8.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CDKN1A—ocular cancer	8.93e-05	8.93e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—AKT1—ocular cancer	8.69e-05	8.69e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EP300—ocular cancer	8.5e-05	8.5e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—HRAS—ocular cancer	8.31e-05	8.31e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—AKT1—ocular cancer	7.94e-05	7.94e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—AKT1—ocular cancer	7.9e-05	7.9e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MYC—ocular cancer	7.41e-05	7.41e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFB1—ocular cancer	7.39e-05	7.39e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—AKT1—ocular cancer	7.33e-05	7.33e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—AKT1—ocular cancer	6.14e-05	6.14e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—ocular cancer	6.08e-05	6.08e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—HRAS—ocular cancer	5.82e-05	5.82e-05	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—AKT1—ocular cancer	5.14e-05	5.14e-05	CbGpPWpGaD
